TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 4047384

Group type: EXPERIMENTAL
Intervention: Propranolol (Inderal)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Atenolol (Tenormin)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 30506745

Group type: EXPERIMENTAL
Intervention: Creatine supplementation (5 g micronized creatine monohydrate daily for three weeks; n=31)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Placebo (n=18)
Number of subjects: 49
Study: 30140739

Group type: EXPERIMENTAL
Intervention: Acute sleep loss
Number of subjects: 0

Group type: COMPARATOR
Intervention: One full night of sleep
Number of subjects: 0
Study: 26989892

Group type: EXPERIMENTAL
Intervention: 800 mg arhalofenate
Number of subjects: 239

Group type: EXPERIMENTAL
Intervention: 600 mg arhalofenate
Number of subjects: 239

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 239

Group type: COMPARATOR
Intervention: 300 mg allopurinol
Number of subjects: 239
Study: 24901666

Group type: EXPERIMENTAL
Intervention: Walking intervention
Number of subjects: 37

Group type: COMPARATOR
Intervention: Non‐intervention control
Number of subjects: 37
Study: 22908679

Group type: EXPERIMENTAL
Intervention: Happy mood with time pressure
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Sad mood with time pressure
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Happy mood without time pressure
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Sad mood without time pressure
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Time pressure present
Number of subjects: 6

Group type: COMPARATOR
Intervention: Time pressure absent
Number of subjects: 6
Study: 19019470

Group type: EXPERIMENTAL
Intervention: Atenolol 50 mg/day
Number of subjects: 69

Group type: COMPARATOR
Intervention: Control group (no atenolol)
Number of subjects: 69
Study: 18045815

Group type: EXPERIMENTAL
Intervention: L-carnitine (20 mg x kg(‐1))
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 16007562

Group type: EXPERIMENTAL
Intervention: Nutritional intervention with Oxepa and Nepro (one can of each during each hemodialysis session for 4 weeks)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control group (20 patients not receiving nutritional intervention)
Number of subjects: 21
Study: 11876241

Group type: EXPERIMENTAL
Intervention: Segmental bioimpedance spectroscopy
Number of subjects: 100

Group type: COMPARATOR
Intervention: Global bioimpedance spectroscopy
Number of subjects: 100
Study: 10454944

Group type: EXPERIMENTAL
Intervention: Educational strategy promoting six recommendations for evaluation and management of dementia, including a mailed American Academy of Neurology continuing medical education course, practice-based tools, an interactive seminar led by local opinion leaders, and follow-up mailings.
Number of subjects: 417

Group type: EXPERIMENTAL
Intervention: Educational strategy promoting six recommendations for evaluation and management of dementia.
Number of subjects: 417

Group type: COMPARATOR
Intervention: Control group (non-intervention).
Number of subjects: 417
Study: 7832339

Group type: EXPERIMENTAL
Intervention: Forced-air warming
Number of subjects: 74

Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 74
Study: 2700179

Group type: EXPERIMENTAL
Intervention: Ketac‐Bond
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Shofu Glasionomer Base Cement
Number of subjects: 90

Group type: COMPARATOR
Intervention: Chemomechanical technique
Number of subjects: 90

Group type: COMPARATOR
Intervention: Conventional mechanical drilling
Number of subjects: 90
Study: 26372

Group type: EXPERIMENTAL
Intervention: Intravenous phentolamine
Number of subjects: 0
Study: 30681802

Group type: EXPERIMENTAL
Intervention: Ceramide containing cleanser and cream with salicylic acid, used twice daily for 28 days.
Number of subjects: 35
Study: 30571205

Group type: EXPERIMENTAL
Intervention: Transcarotid TAVR
Number of subjects: 329
Study: 27399136

Group type: EXPERIMENTAL
Intervention: AA combined with infrahepatic IVC clamping (group A)
Number of subjects: 101

Group type: COMPARATOR
Intervention: AA alone (group B)
Number of subjects: 101
Study: 23911139

Group type: EXPERIMENTAL
Intervention: Exposure near the steel plant
Number of subjects: 61

Group type: COMPARATOR
Intervention: Exposure at the college site
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Interquartile range concentrations of SO2 (2.9 ppb)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Interquartile range concentrations of NO2 (5.0 ppb)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Interquartile range concentrations of CO (0.2 ppm)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Ultrafine particles (10,256 count/cm(3))
Number of subjects: 61
Study: 22402975

Group type: EXPERIMENTAL
Intervention: Intraoperative nerve monitoring (IONM)
Number of subjects: 210

Group type: COMPARATOR
Intervention: Visual inspection of the EBSLN and RLN
Number of subjects: 210
Study: 18671798

Group type: EXPERIMENTAL
Intervention: Sibutramine and weight management
Number of subjects: 10742
Study: 17632223

Group type: EXPERIMENTAL
Intervention: bupropion SR 300 mg/d + high-dose dual nicotine replacement therapy (NRT) + weekly group cognitive behavioral therapy (CBT)
Number of subjects: 51

Group type: COMPARATOR
Intervention: placebo + high-dose dual nicotine replacement therapy (NRT) + weekly group cognitive behavioral therapy (CBT)
Number of subjects: 51
Study: 15188360

Group type: EXPERIMENTAL
Intervention: Experimental intervention (1-hour session with a nurse educator + monthly telephone counseling for 6 months)
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Experimental intervention
Number of subjects: 122

Group type: COMPARATOR
Intervention: Control group (attention placebo: 45-minute video presentation about lupus + monthly telephone calls)
Number of subjects: 122
Study: 11457745

Group type: EXPERIMENTAL
Intervention: Candesartan (n=30)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Calcium antagonists (nifedipine or manidipine) (n=30)
Number of subjects: 60
Study: 10193320

Group type: EXPERIMENTAL
Intervention: Nested PCR
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: In situ hybridisation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Immunocytochemistry
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hematoxylin and eosin (H&E)
Number of subjects: 0

Group type: COMPARATOR
Intervention: H&E and immunocytochemistry
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nested PCR after negative H&E and immunocytochemistry
Number of subjects: 0
Study: 7822113

Group type: EXPERIMENTAL
Intervention: Psychiatric labels (specific labels applied to vignettes)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Types of psychopathology (with and without labels)
Number of subjects: 84
Study: 3284316

Group type: EXPERIMENTAL
Intervention: Intravenous sotalol (1.5 mg/kg load followed by 0.008 mg/kg maintenance, mean dose 150 +/‐ 23 mg)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Oral sotalol (mean dose 583 +/‐ 204 mg daily)
Number of subjects: 16
Study: 30676124

Group type: EXPERIMENTAL
Intervention: VAS-Version of the Working Alliance Inventory (WAI)‐Rehabilitation Dutch Version
Number of subjects: 176

Group type: COMPARATOR
Intervention: Original Version of the Working Alliance Inventory (WAI)‐Rehabilitation Dutch Version
Number of subjects: 176

Group type: COMPARATOR
Intervention: Positive-Packed Version of the Working Alliance Inventory (WAI)‐Rehabilitation Dutch Version
Number of subjects: 176
Study: 28799712

Group type: EXPERIMENTAL
Intervention: Deferred stent implantation
Number of subjects: 1570
Study: 27352488

Group type: EXPERIMENTAL
Intervention: Deep acupuncture at Lianquan (CV 23) and Yifeng (TE 17) combined with swallowing training (twice a day, 20 min per treatment)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Deep acupuncture at Lianquan (CV 23) and Yifeng (TE 17) combined with swallowing training
Number of subjects: 60

Group type: COMPARATOR
Intervention: Swallowing training
Number of subjects: 60
Study: 25243955

Group type: EXPERIMENTAL
Intervention: Telbivudine (LdT) 600 mg once daily
Number of subjects: 118

Group type: COMPARATOR
Intervention: Control (no LdT treatment)
Number of subjects: 118
Study: 22895585

Group type: EXPERIMENTAL
Intervention: HD-MTX-based chemotherapy
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Salvage whole brain radiotherapy
Number of subjects: 126
Study: 20388472

Group type: EXPERIMENTAL
Intervention: Qingshen Granule (1 dosage each time, 3 times a day for one month)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Jiedu Xiezhuo II (retention enema for both groups)
Number of subjects: 60
Study: 18042503

Group type: EXPERIMENTAL
Intervention: Tenofovir DF (TDF) + Lamivudine (3TC) + Efavirenz (EFV)
Number of subjects: 85
Study: 15630062

Group type: EXPERIMENTAL
Intervention: Environmental support intervention (ES)
Number of subjects: 181

Group type: COMPARATOR
Intervention: Control
Number of subjects: 181
Study: 11850136

Group type: EXPERIMENTAL
Intervention: Classroom‐centered (CC) intervention
Number of subjects: 678

Group type: EXPERIMENTAL
Intervention: Family‐school partnership (FSP) intervention
Number of subjects: 678

Group type: COMPARATOR
Intervention: Control classroom
Number of subjects: 678
Study: 9012303

Group type: EXPERIMENTAL
Intervention: Intraoperative forced-air warming via an upper-body blanket (Warm Touch, Mallinckrodt, USA)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Conventional patient insulation with cotton blankets (control group)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Intraoperative forced-air warming
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (no warming therapy)
Number of subjects: 24
Study: 2290141

Group type: EXPERIMENTAL
Intervention: Hyperventilation provocation test (HVPT)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Mental load task (Stroop Color Word Test; CWT)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Psychological state and trait measures (SCL-90 and STAI scores)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Degree of hypocapnia
Number of subjects: 23
Study: 386388

Group type: EXPERIMENTAL
Intervention: Racemic propranolol (high doses)
Number of subjects: 12

Group type: COMPARATOR
Intervention: d-propranolol (d-stereoisomer, practically devoid of beta-blocking activity)
Number of subjects: 12
Study: 31480866

Group type: EXPERIMENTAL
Intervention: Narratives reporting Vaccine Adverse Events (VAE) at 35% frequency
Number of subjects: 564

Group type: EXPERIMENTAL
Intervention: Narratives reporting Vaccine Adverse Events (VAE) at 5% frequency
Number of subjects: 564

Group type: COMPARATOR
Intervention: Control condition with 20% frequency of VAE narratives
Number of subjects: 564
Study: 31291738

Group type: EXPERIMENTAL
Intervention: Educational nutritional intervention (individual, collective, and telephone interventions)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Educational nutritional intervention
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 75
Study: 28647064

Group type: EXPERIMENTAL
Intervention: doktormitSDM training module (two video-based individual coaching sessions of 15 minutes each)
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: doktormitSDM training module
Number of subjects: 152
Study: 26002878

Group type: EXPERIMENTAL
Intervention: IDAP Treatment Program
Number of subjects: 340

Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 340
Study: 23343704

Group type: EXPERIMENTAL
Intervention: palmitoylethanolamide (PEA) 400 mg and transpolydatin 40 mg
Number of subjects: 20

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 20
Study: 21161174

Group type: EXPERIMENTAL
Intervention: Cement Group
Number of subjects: 130

Group type: COMPARATOR
Intervention: Hybrid Group
Number of subjects: 130
Study: 19625064

Group type: EXPERIMENTAL
Intervention: High n-3 OFTT (2:1 n-6/n-3 PUFA ratio)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Low n-3 OFTT (20:1 n-6/n-3 PUFA ratio)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Water control
Number of subjects: 8
Study: 17445927

Group type: EXPERIMENTAL
Intervention: Cisplatin (6 mg/m2 i.v. x20, daily before RT) with RT (35 x 2 Gy)
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Hydr‐Ac‐RT Group (daily i.v. prehydration and accelerated RT)
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Hydr‐Ac‐RT Group
Number of subjects: 121

Group type: COMPARATOR
Intervention: Standard Group
Number of subjects: 121
Study: 15491034

Group type: EXPERIMENTAL
Intervention: 2% dorzolamide hydrochloride eyedrops
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo (artificial tears)
Number of subjects: 17
Study: 11133796

Group type: EXPERIMENTAL
Intervention: Patients with intractable mesial temporal lobe epilepsy
Number of subjects: 62

Group type: COMPARATOR
Intervention: Normal controls
Number of subjects: 62
Study: 9704545

Group type: EXPERIMENTAL
Intervention: Post-operative erectile impairment in sexually active patients (n=104)
Number of subjects: 253

Group type: EXPERIMENTAL
Intervention: Total erectile failure
Number of subjects: 253

Group type: EXPERIMENTAL
Intervention: Retention of ejaculation after TURP
Number of subjects: 253

Group type: EXPERIMENTAL
Intervention: Risk factors for post-operative erectile failure
Number of subjects: 253

Group type: EXPERIMENTAL
Intervention: Incidence of erectile failure after TURP
Number of subjects: 253

Group type: EXPERIMENTAL
Intervention: Incidence of ejaculatory failure
Number of subjects: 253
Study: 8524718

Group type: EXPERIMENTAL
Intervention: Culturally appropriate intervention to increase breast and cervical cancer screening practices
Number of subjects: 1260
Study: 2568792

Group type: EXPERIMENTAL
Intervention: Iotrolan (new contrast medium)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ionic monomeric preparation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nonionic monomeric preparation
Number of subjects: 0
Study: 1014119

Group type: EXPERIMENTAL
Intervention: High-dose medroxyprogesterone
Number of subjects: 20

Group type: COMPARATOR
Intervention: Alcohol infusion of the pituitary
Number of subjects: 20
Study: 30949660

Group type: EXPERIMENTAL
Intervention: Redesigned menu with fruit and vegetable snacks positioned first and last
Number of subjects: 1938

Group type: COMPARATOR
Intervention: Control group with no change to the online menu
Number of subjects: 1938
Study: 28916534

Group type: EXPERIMENTAL
Intervention: Valproic acid
Number of subjects: 382

Group type: COMPARATOR
Intervention: Ethosuximide
Number of subjects: 382
Study: 25499037

Group type: EXPERIMENTAL
Intervention: Transcranial alternating current stimulation with extracephalic return contralateral to the primary stimulating electrode
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Photic stimulation
Number of subjects: 12

Group type: COMPARATOR
Intervention: Fronto-orbital montage
Number of subjects: 12
Study: 23706959

Group type: EXPERIMENTAL
Intervention: Restrictive RBC transfusion policy (hemoglobin <8 g/dL)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Liberal RBC transfusion policy (hemoglobin <10 g/dL)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Quality of life measurement using EuroQol EQ‐5D at day 28
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cost estimation associated with hospitalization for AUGIB in the UK
Number of subjects: 0
Study: 20650654

Group type: EXPERIMENTAL
Intervention: Nocturnal hemodialysis (NHD)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Conventional hemodialysis (HD)
Number of subjects: 51
Study: 18988663

Group type: EXPERIMENTAL
Intervention: Ongoing education consisting of small group sessions and an educational outreach session
Number of subjects: 19

Group type: COMPARATOR
Intervention: No further education (control group)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Ongoing education
Number of subjects: 19
Study: 16911911

Group type: EXPERIMENTAL
Intervention: Clopidogrel 75 mg/day
Number of subjects: 18

Group type: COMPARATOR
Intervention: Aspirin 100 mg/day
Number of subjects: 18
Study: 15224295

Group type: EXPERIMENTAL
Intervention: Gamma-radiation therapy (gamma-RT)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 130
Study: 11282761

Group type: EXPERIMENTAL
Intervention: L-arginine (0.5 g/10 kg body weight)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: L-arginine (1.5 g/10 kg body weight/d)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 9164878

Group type: EXPERIMENTAL
Intervention: Low-A group (AMI patients with low atrial contraction flow velocity)
Number of subjects: 206
Study: 7815238

Group type: EXPERIMENTAL
Intervention: Low-lactose hydrolyzed milk formula
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Lactose-free corn syrup-based milk formula
Number of subjects: 135

Group type: COMPARATOR
Intervention: Standard lactose-containing formula
Number of subjects: 135
Study: 3174786

Group type: EXPERIMENTAL
Intervention: Active marijuana (2.7% delta 9‐THC w/w)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 31295358

Group type: EXPERIMENTAL
Intervention: Empagliflozin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 0
Study: 27773350

Group type: EXPERIMENTAL
Intervention: Fluid resuscitation based on GEDI (goal-directed therapy until GEDI reached 800 mL/m2)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Fluid resuscitation based on central venous pressure (control group)
Number of subjects: 71
Study: 25256125

Group type: COMPARATOR
Intervention: Topical hydrocortisone cream 1% (control group)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Hai's Perianal Support (HPS) toilet seat device (test group)
Number of subjects: 23
Study: 22948945

Group type: EXPERIMENTAL
Intervention: Chitin-glucan (CG) 4.5 g/day
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Chitin-glucan (CG) 1.5 g/day
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Chitin-glucan (CG) 1.5 g/day plus olive oil (OO) extract 135 mg/day
Number of subjects: 130

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 130
Study: 22021533

Group type: EXPERIMENTAL
Intervention: 80 kVp imaging (n = 103)
Number of subjects: 208

Group type: COMPARATOR
Intervention: 100 kVp imaging (n = 105)
Number of subjects: 208
Study: 18598379

Group type: EXPERIMENTAL
Intervention: Probiotics
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study: 16447104

Group type: EXPERIMENTAL
Intervention: Amphotericin B colloidal dispersion (ABCD) 7.5 mg/kg (group A)
Number of subjects: 405

Group type: EXPERIMENTAL
Intervention: Amphotericin B colloidal dispersion (ABCD) 10 mg/kg (group B)
Number of subjects: 405

Group type: EXPERIMENTAL
Intervention: Amphotericin B colloidal dispersion (ABCD) 15 mg/kg (group C)
Number of subjects: 405
Study: 12903909

Group type: EXPERIMENTAL
Intervention: 0.1 mol/l hydrochloric acid instillation
Number of subjects: 20

Group type: COMPARATOR
Intervention: saline instillation
Number of subjects: 20
Study: 10769855

Group type: EXPERIMENTAL
Intervention: Midazolam, nalbuphine, and droperidol administered intravenously, along with nitrous oxide and oxygen by nasal mask.
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: Midazolam, nalbuphine, and droperidol administered intravenously.
Number of subjects: 153
Study: 9069567

Group type: EXPERIMENTAL
Intervention: Lower GIR group (insulin resistance)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Intermediate GIR group (insulin resistance)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Highest GIR group (insulin resistance)
Number of subjects: 33
Study: 8282507

Group type: EXPERIMENTAL
Intervention: Low-osmolar contrast media
Number of subjects: 24

Group type: COMPARATOR
Intervention: High-osmolar contrast media
Number of subjects: 24
Study: 3321540

Group type: EXPERIMENTAL
Intervention: Oral terbutaline 7.5 mg twice daily
Number of subjects: 9
Study: 31955270

Group type: EXPERIMENTAL
Intervention: Mandible reconstruction template tool
Number of subjects: 100
Study: 30600754

Group type: EXPERIMENTAL
Intervention: Intravenous 20 mg nefopam in 100 mL normal saline before spinal anesthesia
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo: intravenous normal saline 100 mL
Number of subjects: 70
Study: 27378824

Group type: EXPERIMENTAL
Intervention: Traditional Chinese Medicine (TCM)
Number of subjects: 182

Group type: COMPARATOR
Intervention: Salbutamol and Montelukast (SM)
Number of subjects: 182
Study: 25753362

Group type: EXPERIMENTAL
Intervention: Standard of Care (StanC) plus an 8-week exercise and education intervention
Number of subjects: 244

Group type: COMPARATOR
Intervention: Standard of Care (StanC)
Number of subjects: 244
Study: 22538472

Group type: EXPERIMENTAL
Intervention: Self-adhering flowable resin composite (Vertise Flow, VF)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Phosphoric acid etching (PAE) with VF
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Self-etch adhesive (SE)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Etch-and-rinse adhesive (E&R)
Number of subjects: 80
Study: 22055594

Group type: EXPERIMENTAL
Intervention: Standard triple therapy (20mg omeprazole bid, 1000mg amoxicillin bid, 500mg clarithromycin bid for 14 days)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Sequential therapy (20mg omeprazole bid and 1000mg amoxicillin bid for 14 days, 500mg ciprofloxacin bid for the first 7 days, 200mg furazolidone bid for the last 7 days)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Control group (CrCl >90 mg/dl)
Number of subjects: 180
Study: 18434749

Group type: EXPERIMENTAL
Intervention: Sevelamer
Number of subjects: 42

Group type: COMPARATOR
Intervention: Calcium
Number of subjects: 42
Study: 17173490

Group type: EXPERIMENTAL
Intervention: Know Your Health (KYH) program (education)
Number of subjects: 347

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 347
Study: 12706405

Group type: EXPERIMENTAL
Intervention: CIV IL-2 (12 mIU/day) for 3 days plus ART
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: CIV IL-2 (12 mIU/day) for 4 days plus ART
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: CIV IL-2 (12 mIU/day) for 5 days plus ART
Number of subjects: 81

Group type: COMPARATOR
Intervention: ART alone
Number of subjects: 81
Study: 11070565

Group type: EXPERIMENTAL
Intervention: Atenolol combined with amlodipine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 8833409

Group type: EXPERIMENTAL
Intervention: Interferon alpha 2b (IFN), 5.0 MU three times a week for one year (n = 48)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Control group (no treatment, n = 50)
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Interferon alpha 2b (IFN)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 98